Colon surpasses breast as leading cancer killer driven by victims under age 50 years, likely mandated into COVID-19 vaccination
Peter A. McCullough, MD, MPH
It
was announced the colon cancer has surpassed malignancies of the breast
as the leading cause of cancer driven by cases before age 50 where
screening colonoscopy starts. This epidemiological shift started in
2021 co-incident with the rollout of the COVID-19 vaccines which were
mandated for a large part of the workforce younger than age 50 years.
Alter AI assisted with this review.
Until
recently colorectal cancer (CRC) was largely a disease of older
adults—typically presenting after 60 years of age. However, within the
last two decades, incidence among individuals younger than 50 has
climbed steadily. By 2024, U.S. registry data showed rates of
early‑onset CRC nearly doubling since the mid‑1990s, with a steep
inflection beginning around 2021 coinciding with mass genetic mRNA
vaccination. Alarmingly, in people under 50, colorectal cancer has now
surpassed breast and lung cancer as the leading cause of cancer‑related
death. This epidemiologic pivot demands scrutiny of both conventional
and under‑examined contributors—including the possibility that oncogenic
COVID-19 vaccines introduced in 2021 may have played a role.